We are live on ! Find out more
CASM

CAS Medical Systems, Inc.
CASM

Delisted

CASM was delisted on the 18th of April, 2019.

0 hedge funds and large institutions have $0 invested in CAS Medical Systems, Inc. in 2019 Q2 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 32 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% less funds holding

Funds holding: 320 (-32)

100% less funds holding in top 10

Funds holding in top 10: 10 (-1)

100% less capital invested

Capital invested by funds: $21.7M → $0 (-$21.7M)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 32

Holders
Holders Change
-32
Holders Change %
-100%
% of All Funds
Holding in Top 10
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
New
Increased
Reduced
Closed
32
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
SAM
26
SignalPoint Asset Management
Missouri
-$457K -2,388 Closed
TRCT
27
Tower Research Capital (TRC)
New York
-$6K -2,380 Closed
Citigroup
28
Citigroup
New York
-$5K -2,000 Closed
UBS Group
29
UBS Group
Switzerland
-$5K -2,000 Closed
Morgan Stanley
30
Morgan Stanley
New York
-$1K -345 Closed
Royal Bank of Canada
31
Royal Bank of Canada
Ontario, Canada
-$1K -300 Closed
Wells Fargo
32
Wells Fargo
California
-$1K -227 Closed

CASM Hedge Fund Activity: Q2 2019 in Review

0 of the 4,604 institutional investors tracked by Wall St. Rank reported a position in CAS Medical Systems, Inc. (CASM) for Q2 2019, worth a combined $0 — down 100% from $21.7M a quarter earlier.

Sellers outnumbered buyers: 32 funds closed out of CASM and 0 opened new positions — a net loss of 32 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was Acuta Capital Partners, exiting entirely with an estimated $12.8M sold.

  • 0 institutional investors held CAS Medical Systems, Inc. (CASM) as of Q2 2019, down from 32 in Q1 2019.
  • Funds reported $0 of CAS Medical Systems, Inc. stock for Q2 2019, down 100% quarter-over-quarter.
  • 0 funds opened new CAS Medical Systems, Inc. positions in Q2 2019 and 32 closed out, a net change of -32 holders.
  • The largest CAS Medical Systems, Inc. seller in Q2 2019 was Acuta Capital Partners, an estimated $12.8M sold.

Based on aggregated 13F filings for Q2 2019.